Literature DB >> 24030676

Late-onset neutropenia: defining limits of neutrophil count in very low birth weight infants.

S Vetter-Laracy1, P-R Balliu1, J A Salinas2, M A Duran3.   

Abstract

OBJECTIVE: To evaluate the incidence, onset, duration, characteristics and importance of late-onset neutropenia (defined as absolute neutrophil count<1500 μl(-1) at 3 weeks of age or later) in a group of very low birth weight (VLBW) infants. STUDY
DESIGN: Routine complete blood cell counts (CBCs) obtained from VLBW infants over a period of 7 years were gathered retrospectively, including those of newborns with weekly CBCs taken over a duration of at least 3 weeks. Data were obtained from between January 2003 and December 2009. RESULT: CBCs of 399 newborns were included. Values were obtained from birth to 36 weeks of postnatal age. Late-onset neutropenia was observed in 259 cases (65%). Neutropenic infants had a mean of 0.5 weeks lower gestational age. Late-onset neutropenia was more frequent in children with intraventricular hemorrhage but not in patients who received erythropoietin. The median age of neutropenia onset was 7 weeks in extremely low birth weight infants and 6 weeks in VLBW infants. The fifth percentile of neutrophils between weeks 3 and 4 was 1280 μl(-1) and between weeks 13 and 15 was 500 μl(-1). The average duration was 2 weeks with normalized values after 18 weeks.
CONCLUSION: A neutrophil count <1500 μl(-1) after the third week of life is frequently observed in VLBW infants and should not be used as a lower reference limit. The fifth percentile varies according to postnatal age from around 1300 μl(-1) in week 4 of life, decreasing to a nadir of 500 μl(-1) between 3 and 4 months of age. Values normalize in the first year of life.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24030676     DOI: 10.1038/jp.2013.111

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  30 in total

Review 1.  The CBC: reference ranges for neonates.

Authors:  Robert D Christensen; Erick Henry; Jeff Jopling; Susan E Wiedmeier
Journal:  Semin Perinatol       Date:  2009-02       Impact factor: 3.300

2.  The number of polymorphonuclear leukocytes in relation to gestational age in the newborn.

Authors:  L Coulombel; M Dehan; G Tchernia; C Hill; M Vial
Journal:  Acta Paediatr Scand       Date:  1979-09

3.  Normal values for mature and immature neutrophils in very preterm babies.

Authors:  B W Lloyd; A Oto
Journal:  Arch Dis Child       Date:  1982-03       Impact factor: 3.791

4.  A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.

Authors:  K Bilgin; A Yaramiş; K Haspolat; M A Taş; S Günbey; O Derman
Journal:  Pediatrics       Date:  2001-01       Impact factor: 7.124

5.  Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study.

Authors:  D S Halpérin; P Wacker; G Lacourt; M Félix; J F Babel; M Aapro; M Wyss
Journal:  J Pediatr       Date:  1990-05       Impact factor: 4.406

6.  Can neutrophil responses in very low birth weight infants predict the organisms responsible for late-onset bacterial or fungal sepsis?

Authors:  S Sarkar; I Bhagat; S Hieber; S M Donn
Journal:  J Perinatol       Date:  2006-06-08       Impact factor: 2.521

7.  Effect of recombinant human erythropoietin administration on peripheral blood neutrophil counts of premature infants.

Authors:  S Mizuno; J Sasaki; C Suzuki; H Kono; S Kojima
Journal:  J Pediatr       Date:  1994-03       Impact factor: 4.406

8.  Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.

Authors:  Robert Carr; Peter Brocklehurst; Caroline J Doré; Neena Modi
Journal:  Lancet       Date:  2009-01-17       Impact factor: 79.321

9.  Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates.

Authors:  A Mouzinho; C R Rosenfeld; P J Sánchez; R Risser
Journal:  Pediatrics       Date:  1994-07       Impact factor: 7.124

10.  A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.

Authors:  E R Gillan; R D Christensen; Y Suen; R Ellis; C van de Ven; M S Cairo
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  1 in total

1.  C-reactive protein for late-onset sepsis diagnosis in very low birth weight infants.

Authors:  Marc Beltempo; Isabelle Viel-Thériault; Roseline Thibeault; Anne-Sophie Julien; Bruno Piedboeuf
Journal:  BMC Pediatr       Date:  2018-01-30       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.